Abstract P3-11-12: Biomarker phase neo-DDRD trial: Predicting response to neoadjuvant chemotherapy (NAC) in early breast cancer using the DNA damage repair deficiency (DDRD) assay by Parkes, EE, James, CR, Lioe, T, Walker, S, Savage, KI, Lowry, K, Knight, L, McCavigan, A, Logan, G, Hurwitz, J, Kirk, SJ, Harkin, P, Kennedy, RD, McIntosh, SA

Get full text

OC-0126: A gene expression assay to predict the risk of distant metastases in localized prostate cancer by Jain, S., Lyons, C., Walker, S., McQuaid, S., Hynes, S., Mitchell, D., Pang, B., Logan, G., McCavigan, A., O'Rourke, D., Davidson, C., Knight, L., Sheriff, A., Berge, V., Neal, D., Pandha, H., Watson, R., Mason, M., Kay, E., Harkin, D., James, J., Salto-Tellez, M., Kennedy, R., O'Sullivan, J., Waugh, D.

Get full text

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology by Walker, Steven M, Knight, Laura A, McCavigan, Andrena M, Logan, Gemma E, Berge, Viktor, Sherif, Amir, Pandha, Hardev, Warren, Anne Y, Davidson, Catherine, Uprichard, Adam, Blayney, Jaine K, Price, Bethanie, Jellema, Gera L, Steele, Christopher J, Svindland, Aud, McDade, Simon S, Eden, Christopher G, Foster, Chris, Mills, Ian G, Neal, David E, Mason, Malcolm D, Kay, Elaine W, Waugh, David J, Harkin, D. Paul, Watson, R. William, Clarke, Noel W, Kennedy, Richard D

Get full text

High EMSY expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum by Hollis, Robert L., Churchman, Michael, Michie, Caroline O., Rye, Tzyvia, Knight, Laura, McCavigan, Andrena, Perren, Timothy, Williams, Alistair R. W., McCluggage, W. Glenn, Kaplan, Richard S., Jayson, Gordon C., Oza, Amit, Harkin, D. Paul, Herrington, C. Simon, Kennedy, Richard, Gourley, Charlie

Get full text

Abstract 322: High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with superior survival and platinum sensitivity by Hollis, Robert L., Churchman, Michael, Rye, Tzyvia, McCavigan, Andrena M., Knight, Laura A., Kennedy, Richard, Herrington, C. Simon, Gourley, Charlie

Get full text

Abstract 283: Identification of a high-risk subgroup in primary prostate cancers presenting with targetable immune biology by Reilly, Emma, McCavigan, Andrena, Walker, Steven M., McCabe, Nuala, Parkes, Eileen, Harkin, Denis P., Kennedy, Richard D., Knight, Laura A.

Get full text

Abstract 1777: Development of a pan-cancer 15 gene expression signature to detect a subgroup driven by MAPK signalling by Knight, Laura A., Price, Bethanie, McCavigan, Andrena, El-Helali, Aya, Gourley, Charlie, Harkin, Denis P., Kennedy, Richard, McCabe, Nuala

Get full text

Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue by Medlow, Paul Wallace, Steele, Christopher James, McCavigan, Andrena Marie, Reardon, Wesley, Brown, Christopher Michael, Lambe, Shauna May, Ishiy, Felipe Augusto Andre, Walker, Steven Michael, Logan, Gemma Elizabeth, Raji, Olaide Yaqeen, Berge, Viktor, Katz, Betina, Kay, Elaine Williamson, Sheehan, Katherine, Watson, Ronald William, Harkin, Denis Paul, Kennedy, Richard Darragh, Knight, Laura Anne

Get full text

A TMA de-arraying method for high throughput biomarker discovery in tissue research by Wang, Yinhai, Savage, Kienan, Grills, Claire, McCavigan, Andrena, James, Jacqueline A, Fennell, Dean A, Hamilton, Peter W

Get full text

Abstract 7: Platinum resistance in epithelial ovarian cancer is dependent on a PDGFR alpha-VEGF-A signalling mechanism that activates downstream angiogenesis pathways by Helali, Aya El, McCabe, Nuala, Steele, Christopher, Perez, Lara Dura, O'Neill, Christina L., Dickson, Naomi, McGivern, Niamh, Harkin, Caolan, McCavigan, Andrena, Medina, Reinhold J., Knight, Laura A., McQuaid, Stephen, James, Jacqueline A., Michie, Caroline O., Gourley, Charlie, McCluggage, W Glenn, Harkin, Denis P., Wilson, Richard H., Stitt, Alan W., Kennedy, Richard D.

Get full text

Abstract MIP-055: IDENTIFICATION OF A MOLECULAR SUBTYPE OF HIGH GRADE SEROUS OVARIAN CANCER REPRESENTING MAPK PATHWAY ACTIVATION AND PLATINUM RESISTANCE by El-Helali, Aya, McCabe, Nuala, Gourley, Charlie, McCavigan, Andrena, Michie, Caroline O., Price, Bethanie, McGivern, Niamh, Churchman, Michael, El-Helai, Aya, O'Brien, Eamonn J., Hill, Laura, Davison, Timothy S, Williams, Alistair, McCluggage, W Glenn, Keating, Katherine E, Harkin, Denis P, Kennedy, Richard

Get full text